Pulmatrix Inc Stock Nasdaq
Equities
US74584P1030
Biotechnology & Medical Research
Sales 2022 | 6.07M 8.3M | Sales 2023 | 7.3M 9.98M | Capitalization | 6.79M 9.29M |
---|---|---|---|---|---|
Net income 2022 | -18M -24.62M | Net income 2023 | -14M -19.15M | EV / Sales 2022 | -3.4 x |
Net cash position 2022 | 34.77M 47.55M | Net cash position 2023 | 10.42M 14.25M | EV / Sales 2023 | -0.5 x |
P/E ratio 2022 |
-0.71
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 22-04-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 19-10-31 |
Director/Board Member | 54 | 20-06-22 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 20-09-30 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |